Stem cells from umbilical cord blood have been successfully used to cure blood diseases and some forms of cancer since 1988.
Currently, great emphasis is placed on scientific research in the field of stem cells. With the evolution of biomedical science and technology in recent years, it is already possible to use stem cells to cure many diseases through their application in regenerative medicine. The development of gene therapy, cell proliferation and stem cell differentiation methods pave the way for many therapeutic applications, which are in the experimental study phase.
Below are mentioned some of the diseases for which hematopoietic stem cell transplants (autologous and allogeneic) have been used therapeutically, as well as the diseases for which clinical research is being done.
Acute myeloid leukemia (AML)
Acute lymphoblastic leukemia (ALL)
Biphenotypic acute leukemia
Neutrophil Actin Deficiency
Ischemic encephalopathy up to the age of 2 years
Chronic myeloid leukemia (LMC)
Chronic lymphocytic leukemia (CLL)
Chronic juvenile myeloid leukemia (JCML)
Chronic juvenile myelomonocytic leukemia (JMML)
Absence of Τ or Β lymphocytes
Absence of T lymphocytes only
Adhesion deficiency of leukocytes
Severe combined immunodeficiency
Χ linked lymphoproliferation alteration
Regeneration after myocardial infarction
Leukemia with plasma cells
Paroxysmal nocturnal hemoglobinuria
The detailed list of diseases with the prospect of stem cell cure is continuously growing.
Diseases or situations that require tissue regeneration are possible candidates for such therapy.